"Abbott is gearing up to release its long-awaited Norvir (ritonavir) tablet. The company states that it will negotiate the price—which has not yet been announced—in good faith. Nonetheless, the Fair Pricing Coalition is already engaged in a vigilant campaign to ensure affordable access to all."
Read more in POZ, June 23, 2009.
0 comments:
Post a Comment